Alectinib Impurities

Show
per page
Impurity structure Parent Drug Name Name of Impurity Catalogue No. CAS No.
Alectinib M1b Metabolite Alectinib

Alectinib M1b Metabolite

VL5710007 N/A
Alectinib M4 Metabolite Alectinib

Alectinib M4 Metabolite

VL5710003 1256585-04-2
Alectinib-D6 Alectinib

Alectinib-D6

DVE00128 1616374-19-6
N-Nitroso Alectinib Impurity Alectinib

N-Nitroso Alectinib Impurity

VE0020152 N/A

Alectinib Related Compound

Alectinib is used to treat non-small-cell lung cancer (NSCLC) that has progressed to other regions of the body.

References

FAQ’s

What type of drug is alectinib?

Alectinib is a tyrosine kinase inhibitor, which is a kind of cancer growth inhibitor. It works by preventing particular chemical messengers from signaling cells to develop. This either prevents or delays the progression of cancer.

Is alectinib used for chemotherapy?

In patients with advanced or metastatic anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer, alectinib is more effective than conventional chemotherapy (NSCLC)

Is Alecensa show immunotherapy action?

Alecensa is a targeted medication used to treat non-small cell lung cancer (NSCLC) with ALK+ gene alterations. It is not immunotherapy. It is a tyrosine kinase inhibitor that kills cancer cells by targeting a specific region in the cell that causes cancer.